ADC Therapeutics SA Ownership 2024 | Who Owns ADC Therapeutics SA Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

0.37%

Insider Ownership

21.06%

Retail Ownership

78.57%

Institutional Holders

15.00

ADC Therapeutics SA Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
REDMILE GROUP, LLC18.69%2.52%15,269,217-59,100-0.39%68,558,784Mar 31, 2024
PROSIGHT MANAGEMENT, LP8.63%8.81%7,050,300578,5008.94%31,655,847Mar 31, 2024
MORGAN STANLEY3.33%0.00%2,720,3951,938,458247.90%12,214,573Mar 31, 2024
GOLDMAN SACHS GROUP INC1.89%0.00%1,540,50980,9955.55%6,916,885Mar 31, 2024
BANK OF AMERICA CORP /DE/1.46%0.00%1,193,847-331,894-21.75%5,360,372,000Mar 31, 2024
MILLENNIUM MANAGEMENT LLC1.24%0.00%1,010,437-1,662,373-62.20%4,536,862Mar 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.1.22%0.01%1,000,0001,000,000100.00%4,490,000Mar 31, 2024
CITADEL ADVISORS LLC1.17%0.00%952,464-900,948-48.61%4,276,563Mar 31, 2024
VANTAGE CONSULTING GROUP INC1.04%2.43%850,737--3,819,809Mar 31, 2024
BLUE OWL CAPITAL HOLDINGS LP0.90%0.66%733,568--3,293,720Mar 31, 2024
SILVERARC CAPITAL MANAGEMENT, LLC0.61%0.63%501,222501,222100.00%2,250,487Mar 31, 2024
MONASHEE INVESTMENT MANAGEMENT LLC0.61%0.27%500,000500,000100.00%2,245,000Mar 31, 2024
GCM GROSVENOR HOLDINGS, LLC0.50%0.28%410,888--1,844,887Mar 31, 2024
MARSHALL WACE, LLP0.30%0.00%243,243221,3951013.34%1,092,161Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.16%0.00%128,400128,400100.00%576,516Mar 31, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC0.15%0.00%120,775120,775100.00%542,280Mar 31, 2024
MIRACLE MILE ADVISORS, LLC0.10%0.01%84,496--379,387Mar 31, 2024
HENNION & WALSH ASSET MANAGEMENT, INC.0.09%0.02%70,6364,7007.13%317,156Mar 31, 2024
MAGNETAR FINANCIAL LLC0.07%0.01%55,762--250,371Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.07%0.00%54,91354,913100.00%246,559Mar 31, 2024

ADC Therapeutics SA's largest institutional shareholder is REDMILE GROUP, LLC, holding 18.69% of the company's total share outstanding, currently valued at $68.56M. The top 10 institutional shareholders own together 39.56% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PROSIGHT MANAGEMENT, LP8.63%8.81%7,050,300578,5008.94%31,655,847Mar 31, 2024
REDMILE GROUP, LLC18.69%2.52%15,269,217-59,100-0.39%68,558,784Mar 31, 2024
VANTAGE CONSULTING GROUP INC1.04%2.43%850,737--3,819,809Mar 31, 2024
BLUE OWL CAPITAL HOLDINGS LP0.90%0.66%733,568--3,293,720Mar 31, 2024
SILVERARC CAPITAL MANAGEMENT, LLC0.61%0.63%501,222501,222100.00%2,250,487Mar 31, 2024
GCM GROSVENOR HOLDINGS, LLC0.50%0.28%410,888--1,844,887Mar 31, 2024
MONASHEE INVESTMENT MANAGEMENT LLC0.61%0.27%500,000500,000100.00%2,245,000Mar 31, 2024
SAXONY CAPITAL MANAGEMENT, LLC0.03%0.11%20,623--92,597Mar 31, 2024
DLK INVESTMENT MANAGEMENT, LLC0.04%0.06%33,155--148,866Mar 31, 2024
AVISO WEALTH MANAGEMENT0.01%0.03%10,46810,468100.00%47,001Mar 31, 2024
HENNION & WALSH ASSET MANAGEMENT, INC.0.09%0.02%70,6364,7007.13%317,156Mar 31, 2024
XTX TOPCO LTD0.03%0.01%24,829-18,821-43.12%111,482Mar 31, 2024
MIRACLE MILE ADVISORS, LLC0.10%0.01%84,496--379,387Mar 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.1.22%0.01%1,000,0001,000,000100.00%4,490,000Mar 31, 2024
MAGNETAR FINANCIAL LLC0.07%0.01%55,762--250,371Mar 31, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC0.15%0.00%120,775120,775100.00%542,280Mar 31, 2024
MILLENNIUM MANAGEMENT LLC1.24%0.00%1,010,437-1,662,373-62.20%4,536,862Mar 31, 2024
EAGLE BAY ADVISORS LLC0.00%0.00%670670100.00%3,008Mar 31, 2024
MARSHALL WACE, LLP0.30%0.00%243,243221,3951013.34%1,092,161Mar 31, 2024
GOLDMAN SACHS GROUP INC1.89%0.00%1,540,50980,9955.55%6,916,885Mar 31, 2024

The largest ADC Therapeutics SA shareholder by % of total assets is PROSIGHT MANAGEMENT, LP. The company owns 7.05M shares of ADC Therapeutics SA (ADCT), representing 8.81% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MORGAN STANLEY3.33%0.00%2,720,3951,938,458247.90%12,214,573Mar 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.1.22%0.01%1,000,0001,000,000100.00%4,490,000Mar 31, 2024
PROSIGHT MANAGEMENT, LP8.63%8.81%7,050,300578,5008.94%31,655,847Mar 31, 2024
SILVERARC CAPITAL MANAGEMENT, LLC0.61%0.63%501,222501,222100.00%2,250,487Mar 31, 2024
MONASHEE INVESTMENT MANAGEMENT LLC0.61%0.27%500,000500,000100.00%2,245,000Mar 31, 2024
MARSHALL WACE, LLP0.30%0.00%243,243221,3951013.34%1,092,161Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.16%0.00%128,400128,400100.00%576,516Mar 31, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC0.15%0.00%120,775120,775100.00%542,280Mar 31, 2024
GOLDMAN SACHS GROUP INC1.89%0.00%1,540,50980,9955.55%6,916,885Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.07%0.00%54,91354,913100.00%246,559Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.04%-28,80028,800100.00%129,312Mar 31, 2024
CITADEL ADVISORS LLC0.03%-27,60027,600100.00%123,924Mar 31, 2024
D. E. SHAW & CO., INC.0.03%0.00%26,92126,921100.00%120,875Mar 31, 2024
CITADEL ADVISORS LLC0.03%-27,10025,4001494.12%121,679Mar 31, 2024
BALYASNY ASSET MANAGEMENT L.P.0.03%0.00%23,76523,765100.00%106,705Mar 31, 2024
COMMONWEALTH EQUITY SERVICES, LLC0.02%0.00%18,81718,817100.00%84,000Mar 31, 2024
SIMPLEX TRADING, LLC0.02%-14,75513,5761151.48%66,000Mar 31, 2024
AVISO WEALTH MANAGEMENT0.01%0.03%10,46810,468100.00%47,001Mar 31, 2024
HENNION & WALSH ASSET MANAGEMENT, INC.0.09%0.02%70,6364,7007.13%317,156Mar 31, 2024
GROUP ONE TRADING, L.P.0.01%0.00%4,7872,555114.47%21,494Mar 31, 2024

As of Mar 31 2024, ADC Therapeutics SA's largest institutional buyer is MORGAN STANLEY. The company purchased 1.94M stocks of ADCT, valued at $12.21M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MILLENNIUM MANAGEMENT LLC1.24%0.00%1,010,437-1,662,373-62.20%4,536,862Mar 31, 2024
AFFINITY ASSET ADVISORS, LLC----1,013,540-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC1.17%0.00%952,464-900,948-48.61%4,276,563Mar 31, 2024
BANK OF AMERICA CORP /DE/1.46%0.00%1,193,847-331,894-21.75%5,360,372,000Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC----144,858-100.00%-Mar 31, 2024
INDIE ASSET PARTNERS, LLC----92,700-100.00%-Mar 31, 2024
HRT FINANCIAL LP----80,086-100.00%-Mar 31, 2024
JANE STREET GROUP, LLC0.03%-26,984-74,276-73.35%121,158Mar 31, 2024
REDMILE GROUP, LLC18.69%2.52%15,269,217-59,100-0.39%68,558,784Mar 31, 2024
XTX TOPCO LTD0.03%0.01%24,829-18,821-43.12%111,482Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)----14,641-100.00%-Mar 31, 2024
EVERGREEN CAPITAL MANAGEMENT LLC----11,000-100.00%-Mar 31, 2024
ADVISOR GROUP HOLDINGS, INC.0.01%0.00%8,000-6,000-42.86%35,920,000Mar 31, 2024
ROYAL BANK OF CANADA0.00%-3,030-1,000-24.81%14,000Mar 31, 2024
FOCUSED WEALTH MANAGEMENT, INC----300-100.00%-Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----207-100.00%-Mar 31, 2024
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO----100-100.00%-Mar 31, 2024
FMR LLC----6-100.00%-Mar 31, 2024
VANTAGE CONSULTING GROUP INC1.04%2.43%850,737--3,819,809Mar 31, 2024
BLUE OWL CAPITAL HOLDINGS LP0.90%0.66%733,568--3,293,720Mar 31, 2024

As of Mar 31 2024, ADC Therapeutics SA's biggest institutional seller is MILLENNIUM MANAGEMENT LLC. The company sold -1.66M shares of ADCT, valued at $4.54M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ADAGE CAPITAL PARTNERS GP, L.L.C.1.22%0.01%1,000,0001,000,000100.00%4,490,000Mar 31, 2024
SILVERARC CAPITAL MANAGEMENT, LLC0.61%0.63%501,222501,222100.00%2,250,487Mar 31, 2024
MONASHEE INVESTMENT MANAGEMENT LLC0.61%0.27%500,000500,000100.00%2,245,000Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.16%0.00%128,400128,400100.00%576,516Mar 31, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC0.15%0.00%120,775120,775100.00%542,280Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.07%0.00%54,91354,913100.00%246,559Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.04%-28,80028,800100.00%129,312Mar 31, 2024
D. E. SHAW & CO., INC.0.03%0.00%26,92126,921100.00%120,875Mar 31, 2024
BALYASNY ASSET MANAGEMENT L.P.0.03%0.00%23,76523,765100.00%106,705Mar 31, 2024
COMMONWEALTH EQUITY SERVICES, LLC0.02%0.00%18,81718,817100.00%84,000Mar 31, 2024
AVISO WEALTH MANAGEMENT0.01%0.03%10,46810,468100.00%47,001Mar 31, 2024
EAGLE BAY ADVISORS LLC0.00%0.00%670670100.00%3,008Mar 31, 2024
UBS GROUP AG0.00%-5151100.00%229Mar 31, 2024
--2020100.00%90Mar 31, 2024

ADC Therapeutics SA's largest new institutional shareholder by number of shares is ADAGE CAPITAL PARTNERS GP, L.L.C., purchased 1.00M shares, valued at $4.49M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
AFFINITY ASSET ADVISORS, LLC----1,013,540-100.00%-Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC----144,858-100.00%-Mar 31, 2024
INDIE ASSET PARTNERS, LLC----92,700-100.00%-Mar 31, 2024
HRT FINANCIAL LP----80,086-100.00%-Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)----14,641-100.00%-Mar 31, 2024
EVERGREEN CAPITAL MANAGEMENT LLC----11,000-100.00%-Mar 31, 2024
FOCUSED WEALTH MANAGEMENT, INC----300-100.00%-Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----207-100.00%-Mar 31, 2024
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO----100-100.00%-Mar 31, 2024
FMR LLC----6-100.00%-Mar 31, 2024

ADC Therapeutics SA's largest sold out institutional shareholder by shares sold is AFFINITY ASSET ADVISORS, LLC, sold -1.01M shares, valued at -, as of undefined.

ADC Therapeutics SA Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
AMERICAN CENTURY MUTUAL FUNDS, INC.0.04%407,550--Jan 31, 2024
ALGER FUNDS0.04%35,000--Jan 31, 2024
AIM GROWTH SERIES (INVESCO GROWTH SERIES)0.00%130,337--Dec 31, 2023
ALPS ETF Trust0.00%44,710--Feb 29, 2024
OHIO NATIONAL FUND INC0.00%20,602--Dec 31, 2023
PRINCIPAL VARIABLE CONTRACTS FUNDS INC0.00%40,200--Dec 31, 2023
MASSMUTUAL PREMIER FUNDS0.00%25,708--Dec 31, 2023
AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC0.00%7,509--Jan 31, 2024
MUTUAL FUND SERIES TRUST0.00%1,068,468--Dec 31, 2023
MML Series Investment Fund II0.00%10,488--Dec 31, 2023
PRINCIPAL FUNDS, INC.0.00%274,400--Feb 29, 2024
VICTORY PORTFOLIOS0.00%1,091--Dec 31, 2023
AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS)0.00%60,321--Dec 31, 2023
COLUMBIA FUNDS SERIES TRUST I0.00%87,562--Feb 29, 2024
Direxion Shares ETF Trust0.00%1,447--Jan 31, 2024
MASSMUTUAL SELECT FUNDS0.00%1,797--Dec 31, 2023

ADC Therapeutics SA's largest mutual fund holder by % of total assets is "AMERICAN CENTURY MUTUAL FUNDS, INC.", owning 407.55K shares, compromising 0.04% of its total assets.

ADC Therapeutics SA Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 2415-57.14%
31 Dec, 2335-16.67%
30 Sep, 2342-26.32%
30 Jun, 2357-
31 Mar, 2357-6.56%
31 Dec, 2261-
30 Sep, 22615.17%
30 Jun, 225823.40%
31 Mar, 2247-9.62%
31 Dec, 21521.96%
30 Sep, 2151-8.93%
30 Jun, 2156-3.45%
31 Mar, 215816.00%
31 Dec, 2050-1.96%
30 Sep, 205127.50%
30 Jun, 2040-

As of 31 Mar 24, 15 institutions are holding ADC Therapeutics SA's shares, representing a decrease of -57.14% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 24304,834-99.10%
31 Dec, 2333,914,079-14.05%
30 Sep, 2339,460,029-12.97%
30 Jun, 2345,339,402-2.65%
31 Mar, 2346,575,01419.97%
31 Dec, 2238,823,1856.06%
30 Sep, 2236,603,9636.06%
30 Jun, 2234,510,9761.22%
31 Mar, 2234,095,3421.05%
31 Dec, 2133,741,7403.03%
30 Sep, 2132,749,359-2.12%
30 Jun, 2133,457,9892.23%
31 Mar, 2132,726,8983.36%
31 Dec, 2031,664,14212.31%
30 Sep, 2028,194,09830.94%
30 Jun, 2021,531,745-

ADC Therapeutics SA (ADCT) has 304.83K shares outstanding as of 31 Mar 24, down -99.10% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 240.37%0.02%
31 Dec, 2341.23%1.76%
30 Sep, 2348.43%1.54%
30 Jun, 2356.11%1.69%
31 Mar, 2357.64%1.64%
31 Dec, 2259.35%2.72%
30 Sep, 2246.70%2.32%
30 Jun, 2244.87%2.28%
31 Mar, 2244.38%2.28%
31 Dec, 2144.16%2.43%
30 Sep, 2142.68%2.24%
30 Jun, 2143.61%2.40%
31 Mar, 2142.66%1.82%
31 Dec, 2048.41%3.06%
30 Sep, 2039.76%3.39%
30 Jun, 2034.25%-

As of 31 Mar 24, ADC Therapeutics SA is held by 0.37% institutional shareholders, representing a 0.02% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 248-33.33%
31 Dec, 2312-29.41%
30 Sep, 2317-32.00%
30 Jun, 2325-26.47%
31 Mar, 2334-8.11%
31 Dec, 223737.04%
30 Sep, 2227-18.18%
30 Jun, 223365.00%
31 Mar, 2220-20.00%
31 Dec, 212519.05%
30 Sep, 2121-27.59%
30 Jun, 2129-17.14%
31 Mar, 213525.00%
31 Dec, 2028-24.32%
30 Sep, 2037-7.50%
30 Jun, 2040-

8 institutional shareholders have increased their position in ADCT stock as of 31 Mar 24 compared to 12 in the previous quarter (a -33.33% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 242-80.00%
31 Dec, 2310-23.08%
30 Sep, 2313-13.33%
30 Jun, 231525.00%
31 Mar, 23129.09%
31 Dec, 2211-47.62%
30 Sep, 2221133.33%
30 Jun, 229-18.18%
31 Mar, 2211-21.43%
31 Dec, 2114-26.32%
30 Sep, 211990.00%
30 Jun, 2110-9.09%
31 Mar, 2111-8.33%
31 Dec, 201271.43%
30 Sep, 207-
30 Jun, 20--

2 institutional shareholders have reduced their position in ADCT stock as of 31 Mar 24 compared to 10 in the previous quarter (a -80.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 2415-57.14%304,834-99.10%0.37%0.02%8-33.33%2-80.00%
31 Dec, 2335-16.67%33,914,079-14.05%41.23%1.76%12-29.41%10-23.08%
30 Sep, 2342-26.32%39,460,029-12.97%48.43%1.54%17-32.00%13-13.33%
30 Jun, 2357-45,339,402-2.65%56.11%1.69%25-26.47%1525.00%
31 Mar, 2357-6.56%46,575,01419.97%57.64%1.64%34-8.11%129.09%
31 Dec, 2261-38,823,1856.06%59.35%2.72%3737.04%11-47.62%
30 Sep, 22615.17%36,603,9636.06%46.70%2.32%27-18.18%21133.33%
30 Jun, 225823.40%34,510,9761.22%44.87%2.28%3365.00%9-18.18%
31 Mar, 2247-9.62%34,095,3421.05%44.38%2.28%20-20.00%11-21.43%
31 Dec, 21521.96%33,741,7403.03%44.16%2.43%2519.05%14-26.32%
30 Sep, 2151-8.93%32,749,359-2.12%42.68%2.24%21-27.59%1990.00%
30 Jun, 2156-3.45%33,457,9892.23%43.61%2.40%29-17.14%10-9.09%
31 Mar, 215816.00%32,726,8983.36%42.66%1.82%3525.00%11-8.33%
31 Dec, 2050-1.96%31,664,14212.31%48.41%3.06%28-24.32%1271.43%
30 Sep, 205127.50%28,194,09830.94%39.76%3.39%37-7.50%7-
30 Jun, 2040-21,531,745-34.25%-40---

ADC Therapeutics SA Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 10, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy8,163,265--8,163,265
May 10, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy6,107,181--6,107,181
May 09, 2024MALLIK AMEETdirector, officer Chief Executive OfficerS-SaleSell29,731$4.48$133.19K1,167,348
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy205,483$3.51$721.35K205,483
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy150,000$3.08$462.36K150,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy150,000$3.26$489.07K150,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy144,517$3.59$518.41K144,517
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy107,590$3.99$429.42K107,590
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$1.93$193.28K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$3.14$314.46K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$2.06$206.14K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$2.10$210.12K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$2.49$248.79K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$2.66$265.71K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$2.17$216.81K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy93,424$2.14$199.90K93,424
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy56,900$1.69$95.89K56,900
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy53,900$1.91$103.03K53,900

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 10, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy8,163,265--8,163,265
May 10, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy6,107,181--6,107,181
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy205,483$3.51$721.35K205,483
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy150,000$3.08$462.36K150,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy150,000$3.26$489.07K150,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy144,517$3.59$518.41K144,517
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy107,590$3.99$429.42K107,590
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$1.93$193.28K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$3.14$314.46K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$2.06$206.14K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$2.10$210.12K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$2.49$248.79K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$2.66$265.71K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$2.17$216.81K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy93,424$2.14$199.90K93,424
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy56,900$1.69$95.89K56,900
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy53,900$1.91$103.03K53,900

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 09, 2024MALLIK AMEETdirector, officer Chief Executive OfficerS-SaleSell29,731$4.48$133.19K1,167,348
Feb 09, 2024Redmile Group, LLC10 percent owner-J-OtherSell59,986$3.25$194.95K1,199,836
Feb 09, 2024Redmile Group, LLC10 percent owner-J-OtherSell19,700$3.25$64.03K1,180,136

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 10, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy8,163,265--8,163,265
May 10, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy6,107,181--6,107,181
May 09, 2024MALLIK AMEETdirector, officer Chief Executive OfficerS-SaleSell29,731$4.48$133.19K1,167,348
Feb 09, 2024Redmile Group, LLC10 percent owner-J-OtherSell59,986$3.25$194.95K1,199,836
Feb 09, 2024Redmile Group, LLC10 percent owner-J-OtherSell19,700$3.25$64.03K1,180,136
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy205,483$3.51$721.35K205,483
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy150,000$3.08$462.36K150,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy150,000$3.26$489.07K150,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy144,517$3.59$518.41K144,517
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy107,590$3.99$429.42K107,590
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$1.93$193.28K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$3.14$314.46K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$2.06$206.14K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$2.10$210.12K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$2.49$248.79K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$2.66$265.71K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy100,000$2.17$216.81K100,000
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy93,424$2.14$199.90K93,424
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy56,900$1.69$95.89K56,900
Feb 09, 2024Redmile Group, LLC10 percent owner-P-PurchaseBuy53,900$1.91$103.03K53,900

The last insider sell of ADC Therapeutics SA's stock was made by MALLIK AMEET on May 09 2024, selling 29,731 shares at $4.48 per share (valued at $133.19K). The last insider buy of ADCT was made by Redmile Group, LLC on May 10 2024, buying 8,163,265 shares at - per share (worth -).

ADC Therapeutics SA Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 202421200.00%
Q1 2024203951.28%
Q4 2010-44-
Q1 201062300.00%
Q4 200952250.00%
Q3 20091250.00%
Q1 200973233.33%
Q4 200873233.33%
Q1 20088--
Q4 200742200.00%
Q2 2007-3-
Q1 2007132650.00%
Q4 2006105200.00%
Q3 2006-1-
Q2 20067--
Q1 2006132650.00%
Q4 200586133.33%
Q3 2005-1-
Q1 2005162800.00%
Q4 200452250.00%

2 total buy trades, and 1 total sell trades (buy/sell ratio of 2.00%) were made by ADC Therapeutics SA's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 202421200.00%
Q1 202420--
Q4 2010---
Q1 2010---
Q4 2009---
Q3 2009---
Q1 20091--
Q4 20082--
Q1 2008---
Q4 2007---
Q2 2007-1-
Q1 2007---
Q4 2006---
Q3 2006---
Q2 20066--
Q1 2006---
Q4 2005---
Q3 2005---
Q1 2005---
Q4 2004---

As of Q2 2024, Insider owners conducted 2 open market buy trades and 1 open market sell trades of ADC Therapeutics SA's stocks.

ADC Therapeutics SA Peer Ownership


TickerCompany
DSGNDesign Therapeutics, Inc.
GBIOGeneration Bio Co.
CRNXCrinetics Pharmaceuticals, Inc.
AKROAkero Therapeutics, Inc.
PASGPassage Bio, Inc.
ARVNArvinas, Inc.
AADIAadi Bioscience, Inc.
STOKStoke Therapeutics, Inc.
IPSCCentury Therapeutics, Inc.
BDTXBlack Diamond Therapeutics, Inc.
RVMDRevolution Medicines, Inc. Warrant
ALXOALX Oncology Holdings Inc.
ALVRAlloVir, Inc.
ALECAlector, Inc.
PTGXProtagonist Therapeutics, Inc.
KURAKura Oncology, Inc.
FIXXQ32 Bio Inc.
RNAAvidity Biosciences, Inc.
RAREUltragenyx Pharmaceutical Inc.

ADCT Ownership FAQ


ADC Therapeutics SA is owned by institutional shareholders (0.37%), insiders (21.06%), and public (78.57%). The largest institutional shareholder of ADC Therapeutics SA is REDMILE GROUP, LLC (18.69% of total shares) and the top mutual fund owner is AMERICAN CENTURY MUTUAL FUNDS, INC. (0.04% of total shares).

ADC Therapeutics SA's major institutional shareholders are REDMILE GROUP, LLC, PROSIGHT MANAGEMENT, LP, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, and BANK OF AMERICA CORP /DE/. The top five shareholders own together 33.99% of the company's share outstanding.

As of Mar 2024, there are 15 institutional shareholders of ADC Therapeutics SA.

REDMILE GROUP, LLC owns 15.27M shares of ADC Therapeutics SA, representing 18.69% of the company's total shares outstanding, valued at $68.56M (as of Mar 2024).

As of Mar 2024, PROSIGHT MANAGEMENT, LP holds 7.05M shares of ADC Therapeutics SA (ADCT), compromising 8.63% of the company, valued at $31.66M.

MORGAN STANLEY is the third largest holder of ADC Therapeutics SA. The company owns 2.72M of the company's shares outstanding (worth $12.21M).